The feasibility of Continuous Positive Airway Pressure (CPAP) treatment for sleep disordered breathing in acute tetraplegia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12606000159550

Enrollment

Registered

2006-05-04

Start date

2007-01-01

Completion date

2007-10-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is designed to examine the feasibility of Continuous Positive Airway Pressure (CPAP) treatment for Obstructive Sleep Apnoea (OSA) in acute tetraplegia. This pilot study will examine how well CPAP is tolerated and if treatment is feasible prior to the commencement of any randomised, controlled trial of therapy.

Interventions

Three months trial of Continuous Positive Airway Pressure (CPAP) treatment for OSA in tetraplegia

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

Acute tetraplegia. All American Spinal Injury Association (ASIA) classifications and lesion levels will be included.

Exclusion criteria

Admission, physician diagnosis of significant head injury, significant pre-existing respiratory or cardiac disease and any other significant co-morbidity. An inability of provide informed consent. Planned hospital discharge within six weeks.

Outcome results